Christopher T. Walsh
Director/Board Member presso The Helen Hay Whitney Foundation
Profilo
Christopher T.
Walsh is the founder of Vicuron Pharmaceuticals LLC (1995), PPD Dermatology LLC (2006), and Proteostasis Therapeutics, Inc. (2006).
He is currently a Director at California Institute for Biomedical Research and a Trustee at The Helen Hay Whitney Foundation.
He was also the President of Dana-Farber Cancer Institute, Inc. and a Trustee at Whitehead Institute for Biomedical Research.
Dr. Walsh's education includes an undergraduate degree from Harvard University and a doctorate from The Rockefeller University.
Dr. Walsh is also the founder of Genzyme Corp...
Posizioni attive di Christopher T. Walsh
Società | Posizione | Inizio |
---|---|---|
The Helen Hay Whitney Foundation | Director/Board Member | - |
California Institute for Biomedical Research
California Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services The California Institute for Biomedical Research provides biomedical research services. The non-profit company is based in La Jolla, CA. | Director/Board Member | - |
Precedenti posizioni note di Christopher T. Walsh
Società | Posizione | Fine |
---|---|---|
PROTEOSTASIS THERAPEUTICS, INC. | Founder | 01/08/2017 |
IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 31/05/2017 |
Harvard Medical School | Corporate Officer/Principal | 01/07/2014 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Director/Board Member | 26/06/2008 |
Critical Therapeutics, Inc. | Director/Board Member | 10/05/2007 |
Formazione di Christopher T. Walsh
Harvard University | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 13 |
---|---|
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Critical Therapeutics, Inc. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
PPD Dermatology LLC
PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
The Helen Hay Whitney Foundation | |
California Institute for Biomedical Research
California Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services The California Institute for Biomedical Research provides biomedical research services. The non-profit company is based in La Jolla, CA. | Commercial Services |
- Borsa valori
- Insiders
- Christopher T. Walsh